Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel DuPage

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Current Opinion in Immunology|March 8, 2013
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune responseMichel DuPage, Tyler Jacks
Cancer Immunology Research|November 15, 2023
Separating the Good from the Bad: Tumor-Infiltrating Tregs Have Increased FucosylationStephanie Silveria, Michel DuPage
Nature Reviews. Immunology|February 16, 2016
Harnessing the plasticity of CD4(+) T cells to treat immune-mediated diseaseMichel DuPage, Jeffrey A Bluestone
Cancer Cell|June 11, 2024
Breaking up the CD8<sup>+</sup> T cell: Treg pas de deuxChenyu Zhang, Alissa Bockman, Michel DuPage
Nature Protocols|June 30, 2009
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinaseMichel DuPage, Alison L Dooley, Tyler Jacks
Immunology|March 14, 2019
Treg programming and therapeutic reprogramming in cancerMariela A Moreno Ayala, Zehui Li, Michel DuPage
Nature|February 10, 2012
Expression of tumour-specific antigens underlies cancer immunoeditingMichel DuPage, Claire Mazumdar, Leah M Schmidt, et al.
Cell Reports|September 12, 2024
Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiationJanneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activationJanneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Epigenetically regulated p53 activity maintains intestinal regulatory T cell identity to prevent inflammationStephanie Silveria, Janneke Gc Peeters, Jenna Vickery, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Current Opinion in Immunology|March 8, 2013
Genetically engineered mouse models of cancer reveal new insights about the antitumor immune responseMichel DuPage, Tyler Jacks
Cancer Immunology Research|November 15, 2023
Separating the Good from the Bad: Tumor-Infiltrating Tregs Have Increased FucosylationStephanie Silveria, Michel DuPage
Nature Reviews. Immunology|February 16, 2016
Harnessing the plasticity of CD4(+) T cells to treat immune-mediated diseaseMichel DuPage, Jeffrey A Bluestone
Cancer Cell|June 11, 2024
Breaking up the CD8<sup>+</sup> T cell: Treg pas de deuxChenyu Zhang, Alissa Bockman, Michel DuPage
Nature Protocols|June 30, 2009
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinaseMichel DuPage, Alison L Dooley, Tyler Jacks
Immunology|March 14, 2019
Treg programming and therapeutic reprogramming in cancerMariela A Moreno Ayala, Zehui Li, Michel DuPage
Nature|February 10, 2012
Expression of tumour-specific antigens underlies cancer immunoeditingMichel DuPage, Claire Mazumdar, Leah M Schmidt, et al.
Cell Reports|September 12, 2024
Hyperactivating EZH2 to augment H3K27me3 levels in regulatory T cells enhances immune suppression by driving early effector differentiationJanneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Biorxiv : the Preprint Server for Biology|April 22, 2024
Increased EZH2 function in regulatory T cells promotes their capacity to suppress autoimmunity by driving effector differentiation prior to activationJanneke G C Peeters, Stephanie Silveria, Merve Ozdemir, et al.
Biorxiv : the Preprint Server for Biology|September 15, 2025
Epigenetically regulated p53 activity maintains intestinal regulatory T cell identity to prevent inflammationStephanie Silveria, Janneke Gc Peeters, Jenna Vickery, et al.
Pageof 4